Job for Medical Representative in Consern Pharma
Consern Pharma Pvt. Ltd. (WHO - GMP Certified Company) Urgently requires unit head for its manufacturing unit having tablets & capsule section at ludhiana
Post: Medical Representative
Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Oral Solution, 10 mg/mL, the generic version of Vimpat® Oral Solution, 10 mg/mL of UCB, Inc. Glenmark will market this product upon receiving final approval of its Lacosamide Oral Solution, 10 mg/mL ANDA. The patent listed in the Orange Book for Vimpat® Oral Solution, 10 mg/mL is scheduled to expire on March 17, 2022.
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Naproxen Sodium Tablets USP, 220 mg (OTC). This product is expected to be launched in Q1 FY16-17.
Delhi high court gave temporary relief to Pfizer, Abbott and Macelods over health ministry's ban on certain fixed dose combinations (FDCs). The permit is provided till 21st march from governments ban on these companies products.